Abstract Number: 1431 • 2018 ACR/ARHP Annual Meeting
Kikuchi-Fujimoto Disease: A Retrospective Analysis of 23 Pediatric Cases from a US Center
Background/Purpose: Kikuchi-Fujimoto Disease (KFD) is often described as a benign self-limited disease. However, there is a risk of recurrence. It is most common in adult…Abstract Number: 1432 • 2018 ACR/ARHP Annual Meeting
Engaging Patients and Parents to Improve Mental Health for Youth with Rheumatologic Disease
Background/Purpose: Mental health conditions are common in youth with rheumatologic disease, yet intervention strategies are understudied. We used a patient-engaged approach to investigate the mental…Abstract Number: 1433 • 2018 ACR/ARHP Annual Meeting
The Role of Patient and Parental Resilience in Amplified Musculoskeletal Pain Syndrome
Background/Purpose: Resilience is a dynamic process of positive adaptation in the context of significant adversity. While higher levels of resilience have been associated with improved…Abstract Number: 1434 • 2018 ACR/ARHP Annual Meeting
Patient-Proxy Agreement on Health-Related Quality of Life in Juvenile Fibromyalgia Syndrome
Background/Purpose: The administration of proxy-reported health-related quality of life (HRQoL) measures in the assessment of juvenile fibromyalgia syndrome (JFMS) is common but its added clinical…Abstract Number: 1435 • 2018 ACR/ARHP Annual Meeting
Hormonal Contraception Use and Capacity to Self-Screen for Contraindications Among Adolescents in a Pediatric Rheumatology Clinic
Background/Purpose: Many states allow pharmacists to prescribe combined hormonal contraception (HC), eliminating the barrier of a provider visit. For adolescent rheumatology patients, however, a clinician…Abstract Number: 1436 • 2018 ACR/ARHP Annual Meeting
Pregnancy Outcomes in Partners of DMARD Exposed Men with Juvenile Idiopathic Arthritis – an Observational Study
Background/Purpose: Males account for about one third of all cases of juvenile idiopathic arthritis (JIA). During the course of the disease and often into adulthood,…Abstract Number: 1437 • 2018 ACR/ARHP Annual Meeting
Use,Safety and Efficacy of Thalidomide from a Tertiary Level Pediatric Rheumatology Centre in India
Background/Purpose: Thalidomide is an effective agent for several pediatric rheumatic diseases: SOJIA, Behcet's disease and recalcitrant skin disease in cSLE to name a few. Systemic…Abstract Number: 1438 • 2018 ACR/ARHP Annual Meeting
Treatment and Response of Down Syndrome Arthropathy
Background/Purpose: Of the very few studies describing Down syndrome arthropathy (DA), crude prevalence estimates indicate DA maybe as common as juvenile idiopathic arthritis (JIA), however,…Abstract Number: 1439 • 2018 ACR/ARHP Annual Meeting
Yellow Fever Vaccination in Brazil: Short-Term Safety in Pediatric Autoimmune Rheumatic Diseases
Background/Purpose: Yellow fever (YF) immunization is not routinely performed in juvenile autoimmune rheumatic disease (ARD) patients. However, during the recent epidemic campaign in state of…Abstract Number: 1440 • 2018 ACR/ARHP Annual Meeting
Systemic Sclerosis in Pediatric Patients: An Epidemiological Study in a Large Insured Population in the US
Background/Purpose: Systemic sclerosis (SSc) is a very rare autoimmune disorder and only very few population-based epidemiological studies described its incidence and prevalence in children. In…Abstract Number: 1441 • 2018 ACR/ARHP Annual Meeting
Diagnostic Performances of Antibodies Against Carbamylated Proteins in US Based Populations with Rheumatoid Arthritis and Other Autoimmune Rheumatic Diseases
Background/Purpose: Recently, antibodies directed against carbamylated antigens (anti-CarP antibodies) were identified in rheumatoid arthritis (RA). Studies have established the predictive and prognostic value of this…Abstract Number: 1442 • 2018 ACR/ARHP Annual Meeting
Differential Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry and a Universal Metabolome Standard Reveals a Metabolome Profile with Consistent Accuracy for Rheumatoid Arthritis
Background/Purpose: Early diagnosis of rheumatoid arthritis (RA) is hampered by suboptimal accuracy of currently available serological biomarkers. Recent advancements in metabolomic profiling include dansylation liquid…Abstract Number: 1443 • 2018 ACR/ARHP Annual Meeting
Ultrasonographic Criteria for the Diagnosis of Erosive Rheumatoid Arthritis Disease Using Osteoarthritic Patients As Controls Compared to Validated Radiographic Criteria
Background/Purpose: Rheumatoid arthritis (RA) is the most prevalent chronic inflammatory joint disease (1,2) responsible for structural damage. Radiography (RX) is considered as the gold standard…Abstract Number: 1444 • 2018 ACR/ARHP Annual Meeting
Optimization of Ultrasonographic Examination for the Diagnosis of Erosive Rheumatoid Arthritis Versus Erosive Osteoarthritis with Radiography Considered As Gold Standard
Background/Purpose: Rheumatoid arthritis (RA) is the most prevalent chronic inflammatory joint disease (1,2) responsible for structural damage. Radiography (RX) is considered as the gold standard…Abstract Number: 1445 • 2018 ACR/ARHP Annual Meeting
MRI Bone Erosions in RA Patients Relatives with Clinically Suspicious Arthralgia
Background/Purpose: Rheumatoid arthritis (RA) has a preclinical phase without symptoms that progress to symptomatic phases. Clinically suspect arthralgia (CSA) refers to patients with symptoms without…